Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 61,514 shares at $63.38 ($3.9M) on 2024-07-15, disclosed to the SEC on 2024-07-17.
Scheduled sale ($3.9M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.38 | 11,000 | $697K | 17.8% |
| 2 | $64.27 | 22,000 | $1.4M | 36.1% |
| 3 | $63.16 | 14,257 | $900K | 23.0% |
| 4 | $63.16 | 14,257 | $900K | 23.0% |
| Total | $63.60 avg | 61,514 | $3.9M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-06-24 | $1.2M | — | Filing → |